Use of Synvisc® in Knee Osteoarthritis - Survey on Practice

Study of prescription methods in everyday medical practice, tolerance profile and effect of Synvisc® until six months of follow-up.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Osteoarthritis Arthritis Joint Diseases Musculoskeletal Diseases Rheumatic Diseases

Sex eligibility

All sexes

Study type

Observational

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

not applicable

Exclusion criteria

none

Treatment and study plan

Synvisc®

Drug

Primary outcomes

Change in clinical symptoms

Time frame: up to 6 months

assessed via questionnaire
Amount of medication consumed

Time frame: up to 6 months
Patient satisfaction on a 4-point verbal rating scale

Time frame: up to 6 months

Secondary outcomes

Number of patients with adverse events

Time frame: up to 6 months

Sponsors and collaborators

Lead sponsor

Boehringer Ingelheim

Industry

Registry information

Official study title

Use of SYNVISC in Knee Osteoarthritis. Survey on Practice. "U.S.A.G.E Pratique"

Important dates

Study start: 1998
Primary completion: 2000
First posted: Jul 21, 2014
Registry last updated: Jul 21, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed